Cornforth
Andrew Cornforth, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20140308316 | ANTIGEN PRESENTING CANCER VACCINE WITH GAMMA INTERFERON - The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC. Class II. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells. | 10-16-2014 |
20140314814 | ANTIGEN PRESENTING CANCER VACCINE - The disclosure provides reagents, methods, and kits, for treating melanoma. The reagent encompasses interferon-gamma (IFN-gamma) responsive melanoma cells, where the cells are autophagic and non-apoptotic melanoma cells, and where the cells express MHC Class if. In another aspect, the reagent encompassed dendritic cells loaded with the IFN-gamma responsive, non-apoptotic, MHC Class II-expressing melanoma cells. | 10-23-2014 |
20150064217 | PLURIPOTENT GERM LAYER ORIGIN ANTIGEN PRESENTING CANCER VACCINE - The disclosure provides reagents, methods, and kits, for treating or preventing cancers derived from each of the germ layers (endoderm, mesoderm, ectoderm, neural crest). The reagent encompasses interferon-gamma (IFN-gamma) responsive cancer cells, where the cells are autophagic and non-apoptotic cancer cells, and where the cells express MHC Class II. | 03-05-2015 |
Andrew Cornforth, Mission Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20150238586 | Rapid Method Production High Purity Cancer Stem Cells and Population of High Purity Cancer Stem Cells - The disclosure provides reagents, including cells, and related methods, useful for administering to subjects with a neoplastic disorder. The reagents and methods encompass cancer stem cells of enhanced purity. Neoplastic disorder encompasses melanoma, ovarian cancer, colorectal cancer, breast cancer, and lung cancer. | 08-27-2015 |
20150322397 | Bioreactor Cartridge and System - A bioreactor with a removable reactor core having internal growth chambers, a first end with an inlet upstream from said core; a second end downstream with an outlet from said core; and, a pumping means to provide media flow, is disclosed. | 11-12-2015 |
Andrew N. Cornforth, Irvine, CA US
Patent application number | Description | Published |
---|---|---|
20160022789 | INDIVIDUALIZED HIGH PURITY COLON CARCINOMA STEM CELLS, METHODS AND USE OF THE SAME - The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as colon carcinoma (CC). Methods for preparing and purifying the cancer stem cells are provided. | 01-28-2016 |
Peter Cornforth, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20140032400 | Mobile Savings Account - System and method of operating a savings account | 01-30-2014 |
20140057594 | Cellular Airtime Management - Method and system for crediting cellular accounts with airtime comprising exchanging funds within a mobile telephone based money transfer system account for airtime. Crediting a plurality of cellular accounts with the airtime. | 02-27-2014 |
20140058928 | Mobile Money Transfer - Method and system method for transferring funds in a mobile telephone based money transfer system comprising receiving a request for an amount of electronic funds. Debiting the amount of funds from the mobile telephone based money transfer system account, wherein the account is allowed to go or remain overdrawn following the debit. | 02-27-2014 |
Peter Cornforth, Newbury GB
Patent application number | Description | Published |
---|---|---|
20140195427 | MOBILE TRANSACTIONS - A method for analysing mobile handset based transactions between sender handsets and receiver handsets comprising the steps of: identifying locations of a sender handset and a receiver handset for each transaction using mobile base station information; determine a geographical distribution of mobile handset based transactions based on the identified locations; and identifying anomalies by comparing the determined geographical distribution with an expected geographical distribution. | 07-10-2014 |